Related Experiment Video
Updated: Jun 26, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Prevention of cervical cancer: where immunology meets diagnostics
Chris J L M Meijer1, Daniëlle A M Heideman, Hans Berkhof
1Department of Pathology, Vrije Universiteit Medical Center, Amsterdam, Netherlands. cjlm.meijer@vumc.nl
Abstract:
Based on the insight that cervical cancer is caused by high-risk human papillomavirus (hrHPV) types, two new directions of cervical cancer prevention have emerged: primary prevention by prophylactic vaccination against hrHPV types 16 and 18, and secondary prevention by cervical screening with HPV DNA testing. These "current views" elaborate on both prevention modes in the context of public health. It is argued that within the next decades using current vaccines the most effective way of prevention and control of cervical cancer requires an integrated vaccination-screening approach, including routine prophylactic vaccination to pre-pubertal women and adapted cervical screening for older women.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cancer Prevention
Some...
Cancer Prevention
Some...
Preventive Healthcare Services
